Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-phase study of lentiviral RAG1/RAG2 gene transduction in donor CD34+ hematopoietic stem cells
NL-OMON55430Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2018
- Countries
- 1
01
Overview
Open-label trial in severe combined immunodeficiency (SCID) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Successful transduction of fresh CD34+ hematopoietic stem cells. Started Dec 2018; status: recruiting.
02
Conditions
severe combined immunodeficiency (SCID)
Beyond the preview
Go deeper on NL-OMON55430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55430.